Clinical Trials Logo

Clinical Trial Summary

Safety and performance of an anti-microbial vascular graft in the treatment of aneurysmal and occlusive disease of the abdominal aorta.


Clinical Trial Description

The purpose of this multi center, single arm study is to demonstrate the safety and performance of the Second Generation Anti-Microbial (InterGard Synergy) vascular graft in the treatment of aneurismal and occlusive diseases of the abdominal aorta.

The primary endpoint is the assessment of primary and secondary graft patency. The secondary endpoints were the assessment of adverse events and the assessment of triclosan and silver contents in the serum over the time. ;


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01710878
Study type Interventional
Source Maquet Cardiovascular
Contact
Status Completed
Phase N/A
Start date February 2008
Completion date December 2012

See also
  Status Clinical Trial Phase
Completed NCT03974958 - Circulating microRNAs and Degenerative Abdominal Aorta Aneurysm N/A
Completed NCT04691726 - Impact of Intra- and Postoperative Continuous Infusion of Lidocaine on Analgesia in Vascular Anaesthesia Phase 4